Endocrine cases are challenging when horses present in the early stages of disease, when diagnostic tests yield equivocal results, or when patients fail to respond to standard management protocols. Other patients may be challenging if they develop rarer manifestations of common endocrine diseases or suffer from more than one endocrine disorder at the same time. Treatment selection and patient monitoring also present challenges when horse owners obtain information from various sources or receive conflicting advice, or at times when nutraceuticals are substituted for medical treatments. Equine metabolic syndrome and pituitary pars intermedia dysfunction will be discussed in this interactive session, along with rarer endocrine disorders such as hyperparathyroidism if information is requested.
As questions arise about equine endocrinology cases, it is useful for colleagues to share information about their experiences and discuss current diagnostic and treatment protocols. Results of recent studies should also be incorporated into discussions so that evidence-based recommendations are made whenever possible.
In the weeks leading up to this interactive session, diplomates will be invited to submit questions via a survey distributed on the ACVIM-LA listserve. Attendees will also be invited to pose questions during the session using an audience response system and polls will be conducted to assess the use of specific diagnostic tests, management protocols, or medical treatments.